In many species, introduction of double-stranded RNA (dsRNA) induces potent and specific gene silencing, a phenomenon called RNA interference or RNAi. The apparently widespread nature of RNAi in ...

Research and Markets has announced the addition of "Gene Silencing with RNA Interference: A New Generation of Pharmaceuticals" to their offering. For 50 years since the discovery the DNA double helix, ...

Ten years ago, researchers obtained the first crystal structure of Dicer, a key enzyme in a biological process called RNA interference (RNAi). In RNAi, a process also known as gene silencing, a short ...

RNA interference (RNAi) is making great strides as an indispensable strategy for target-specific knockdown of gene expression. Emerging second-generation technologies represent advances in RNAi design ...

RNA interference (RNAi) therapeutics have garnered significant attention in clinical research due to their potential for treating various diseases, including genetic disorders, viral infections and ...

ノボ ノルディスクが、11月18日に発表したプレスリリースの翻訳版です。内容や解釈については、正式言語である英語が優先されます。 英文オリジナル版は、こちら(novonordisk.com)をご参照ください。 提携によりDicerna社のGalXC™技術を利用し、多数の臨床治療 ...

The Marina/Debiopharm Research and Development (R&D) team has selected and confirmed the lead DiLA2 formulation for a RNAi-based therapy for the treatment of non-muscle invasive bladder cancer. This ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, is hosting a virtual R&D Day today. During the event, the Company plans to ...